Our analysis also indicated that the three members of the aldo-keto-reductase-1C (AKR1C) family (AKR1C1, AKR1C2, AKR1C3) correlated with resistance to GPX4 inhibitors in lung cancer CLs (Figure 6H). The gene discussed is AKR1C2; the disease is lung carcinoma.